Oral Antihistamines for Itching and Local Swelling
For treating itching and local swelling, start with non-sedating second-generation H1 antihistamines as first-line therapy—specifically cetirizine, loratadine, fexofenadine, desloratadine, or levocetirizine taken once daily. 1
Non-Sedating Options (First-Line)
The following non-sedating antihistamines are appropriate:
- Cetirizine 10 mg once daily - fastest time to maximum concentration, may cause mild sedation at higher doses 1
- Loratadine 10 mg once daily 1
- Fexofenadine 180 mg once daily 2
- Desloratadine once daily - longest half-life at 27 hours 1
- Levocetirizine once daily 1
Offer patients a choice of at least two different non-sedating antihistamines, as individual responses and tolerance vary significantly 1. If one agent fails to provide adequate relief, switch to another before escalating therapy.
Dose Escalation Strategy
If standard doses prove inadequate, increase the dose up to four times the manufacturer's recommended amount when benefits outweigh risks 1, 3. This off-label practice has become common and is supported by evidence showing enhanced symptom control without compromising tolerability 3.
Sedating Antihistamines (Second-Line or Adjunctive)
While less commonly used as monotherapy due to concerns about reduced concentration and performance, sedating antihistamines remain effective options:
Adding a sedating antihistamine at night to a non-sedating antihistamine during the day may help patients sleep better, though it provides little additional clinical effect on the underlying condition if H1 receptors are already saturated 1.
Antihistamines Safe in Pregnancy
While it's best to avoid all antihistamines during pregnancy (especially first trimester), when treatment is necessary, chlorphenamine is the preferred choice in the UK due to its long safety record 1.
Pregnancy-Specific Recommendations:
- Chlorphenamine: Most commonly chosen by UK clinicians for its established safety profile 1
- Loratadine and cetirizine: Classified as FDA Pregnancy Category B drugs with no evidence of fetal harm, though well-controlled human studies are lacking 1
- First-generation antihistamines generally: Meta-analysis of 200,000 first-trimester exposures showed no increased teratogenic risk 4
- AVOID hydroxyzine: Specifically contraindicated in early pregnancy 1
All antihistamines are considered safe during breastfeeding, as minimal amounts are excreted in breast milk 5.
Important Caveats and Adjustments
Renal Impairment:
- Moderate impairment (CrCl 10-20 mL/min): Avoid acrivastine; halve doses of cetirizine, levocetirizine, and hydroxyzine 1
- Severe impairment (CrCl <10 mL/min): Avoid cetirizine, levocetirizine, and alimemazine; use loratadine and desloratadine with caution 1
Hepatic Impairment:
- Contraindicated: Mizolastine in significant hepatic impairment 1
- Avoid: Alimemazine (hepatotoxic), chlorphenamine and hydroxyzine in severe liver disease (inappropriate sedation) 1
Cardiac Considerations:
Mizolastine is contraindicated in clinically significant cardiac disease and prolonged QT interval; avoid concurrent use with drugs that inhibit hepatic metabolism (macrolide antibiotics, imidazole antifungals) or have arrhythmic properties 1
Additional Therapeutic Options
If H1 antihistamines alone provide inadequate control, consider adding an H2 antihistamine (e.g., fexofenadine plus cimetidine) for potentially better control, though this is off-license 1, 2. The combination may be more helpful for accompanying dyspepsia than for the primary condition itself 1.